CLEVELAND, Aug. 01, 2017 -- Bravo, a nationwide wellness provider, is pleased to announce that it has renewed its partnership with Hooper Holmes, Inc. (OTCQX:HPHW) as preferred biometric screening and flu vaccination partner. Since the company launched 9 years ago, Bravo has relied upon Hooper Holmes as a preferred partner for biometric screenings, having delivered over 25,000 events and 700,000 individual screenings together.
|
|||
“Bravo and Hooper have a tremendous working relationship that has evolved with technology and the changing marketplace,” said Jim Pshock, Bravo Wellness Founder and CEO. “We are excited by Hooper’s growth and their expanding health provider network, which has now reached more than 20,000. Great partnerships require commitment to service excellence and that is what Hooper Holmes continues to provide as one of our key partners.”
Hooper Holmes, Inc., a leading provider of health, wellness and biometric screening services, provides on-site biometric screenings and seasonal flu vaccinations for Bravo’s extensive client base. The core offering features a comprehensive venipuncture screening along with measured biometrics.
“We applaud Jim and the Bravo team for providing best-in-class health and well-being programs for their members,” said Henry Dubois, CEO of Hooper Holmes. “As we have ramped up our service model, expanded our health provider network through our recent merger, and renewed our commitment to the Bravo team, Hooper is well-positioned to assist Bravo in leveraging screenings as a meaningful face-to-face interaction that builds confidence in their wellness program and provides a launching pad for interest in continued program engagement post-screening.”
On-site screenings and flu vaccinations feature Hooper’s nationwide health professional network and technology platforms including its proprietary, ScreeningPro™ tablet technology with online/offline paperless sign-in capabilities.
About Bravo Wellness
Founded in 2008, Bravo’s mission is to inspire people to achieve their personal best. By focusing on individual improvement, Bravo helps employers and health plans leverage wellness to strengthen employee benefits and drive down the long-term claims trend. Their data-driven approach has established proven models for controlling rising healthcare costs, inspiring personal improvement and strengthening existing benefits into a competitive advantage. For more information, visit www.bravowell.com.
About Hooper Holmes
Hooper Holmes mobilizes a national network of health professionals to provide on-site health screenings, laboratory testing, risk assessment and sample collection services to wellness and disease management companies, employers and brokers, government organizations and academic institutions nationwide. For more information, visit www.hooperholmes.com.
Contacts Bravo Corporate Marketing 877.662.7286 Hooper Holmes Henry E. Dubois, CEO 913.764.1045


Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 



